bomedemstat
imago biosciences
[]
imago biosciences presents positive data from ongoing phase 2 study of bomedemstat in essential thrombocythemia at eha 2022 - the study completed enrollment with 73 patients in april 2022 - - as of the data cutoff of 29 april 2022, bomedemstat demonstr... 
CEO Of Digital Media Online